Inactief instrument

Andere talen Integrity Applications, Inc. Other OTC

Aandelen

IGAP

US45824Q1013

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION	02/05
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT	22/04
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	22/04
GlucoTrack, Inc. announced that it has received $0.5 million in funding	22/04
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	16/04
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING	16/04
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring	16/04
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	02/04
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor	02/04
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY	12/03
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	27/02
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS	13/02
Glucotrack, Inc Announces Appointment of Luis Malavé as Chairman of Its Board of Directors	13/02
GlucoTrack Inc. : GlucoTrack veröffentlicht die ersten Daten zur Messgenauigkeit seines implantierbaren Geräts für die kontinuierliche Glukoseüberwachung	08/02
GlucoTrack Says Implantable Glucose Monitor Safe With High Level of Accuracy; Shares Rise	02/01
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor	02/01
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR	02/01
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT	30/11
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Integrity Applications, Inc. Other OTC

Aandelen

IGAP

US45824Q1013

Andere talen

Filters